YAR PYE Company Limited Pharmaceutical Import Profile — Myanmar (DGFT 2022–2026)

Name: YAR PYE Company Limited Pharmaceutical Import Records from India — 3 Products, $850.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

YAR PYE Company Limited — Pharmaceutical Importer Profile (2026) | 3 Products, $850.0K Trade | TransData Nexus

YAR PYE Company Limited

Pharmaceutical Importer · Myanmar · Antifungals Focus · $850.0K Total Trade · DGFT Verified

YAR PYE Company Limited is a pharmaceutical importer based in Myanmar with a total trade value of $850.0K across 3 products in 3 therapeutic categories. Based on 17 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. YAR PYE Company Limited sources from 4 verified Indian suppliers, with Maan Pharmaceuticals Limited accounting for 77.2% of imports.

YAR PYE Company Limited — Import Portfolio & Supplier Network

YAR PYE Company Limited import network — 3 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to YAR PYE Company Limited?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Maan Pharmaceuticals Limited	$1.2M	64	77.2%
Swipha Exports Private Limited	$293.3K	42	19.3%
Synokem Pharmaceuticals Limited	$31.7K	7

What Formulations Does YAR PYE Company Limited Import?

Formulation	Value	Ships
Cefino-100 TAB. (cefixime 100MG TAB.)	$115.5K	3
Manox dry suspension (amoxicillin oral	$113.5K	3
Manoxcla v -1200 (amoxycillin 1000MG	$106.0K	3
Metop (metoclopramide hcl 5MG/ML)	$105.3K	3
Candiket - 200 (ketoconazole 200MG TAB.)	$104.2K	3
Parafen forte TAB. ibuprofen 400 +paracetamol 325MG.TAB. Box of	$100.0K	2
Parafen forte TAB.(ibuprofen 400 +paracetamol 325MG.TAB.)(Box of 10x10 tablet, total 6075000 tablet	$63.8K	3
Parafen forte TAB ibuprofen 400+paracetamol 325MG TAB. Pack: Box of 10x10 as per	$44.4K	1
Manceph-500 cap. cephalexin 500MG. cap. Box of	$41.5K	2
Manceph - 500 cap.(cephalexin 500 MG. cap.) (10000 Box of 10 x 10 cap =1000000 cap.)	$41.5K	1
Parafen forte TAB (ibuprofen 400 +	$40.5K	1
Cleniclox-500 cap. ampicillin 250MG. +cloxacillin 250 cap. Box of	$26.5K	2
Manceph-500 cap cephalexin 500 MG cap Pack: Box of 10x10 as per	$21.5K	1
Oman - 20 capsule ( omeprazole 20 MG cap) ( Box of 10x10 )	$20.6K	3
Cleniclox -500 cap. ampicillin 250MG +cloxacillin 250 cap Pack: Box of 10x10 as per	$18.7K	1

YAR PYE Company Limited imports 81 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 3 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Ketoconazole	Antifungals	$350.0K	7	0.9%	11
2	Cefixime	Advanced Antibiotics	$300.0K	6	0.2%	7
3	Metoclopramide	Gastrointestinal	$200.0K	4	0.9%	3

YAR PYE Company Limited imports 3 pharmaceutical products across 3 categories into Myanmar totaling $850.0K.

YAR PYE Company Limited — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

YAR PYE Company Limited is a pharmaceutical importer based in Yangon, Myanmar. Established to meet the growing demand for quality healthcare products, the company specializes in sourcing and distributing finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Operating as a key player in Myanmar's pharmaceutical supply chain, YAR PYE Company Limited collaborates with various international suppliers to ensure a steady supply of essential medications to the local market.

2Distribution Network

The company's distribution network is centered in Yangon, Myanmar's commercial hub, facilitating efficient logistics and access to a broad customer base. While specific warehouse locations and logistics capabilities are not publicly detailed, the strategic positioning in Yangon suggests a well-established infrastructure capable of supporting nationwide distribution. This centralization enables YAR PYE Company Limited to effectively manage inventory and respond promptly to market demands across Myanmar.

3Industry Role

YAR PYE Company Limited functions primarily as a pharmaceutical importer and distributor within Myanmar's healthcare sector. By sourcing finished pharmaceutical formulations from international suppliers, the company plays a crucial role in bridging the gap between global manufacturers and the local market, ensuring the availability of a diverse range of medications to meet the therapeutic needs of the population.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — YAR PYE Company Limited

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

The company's sourcing strategy exhibits a high degree of concentration, with a total import value of $850,000 USD from India across 17 shipments, importing 81 unique formulations. The top three products—Ketoconazole, Cefixime, and Metoclopramide—account for 100% of the import value, indicating a focused product portfolio. This concentration may pose risks related to supply chain disruptions or regulatory changes in India. However, it also suggests a strategic choice to specialize in high-demand therapeutic areas, potentially enhancing operational efficiency and market expertise.

2Supply Chain Resilience

YAR PYE Company Limited's supply chain resilience is closely tied to its reliance on a limited number of Indian suppliers. The primary supplier, MAAN Pharmaceuticals Limited, accounts for 77.2% of the total import value, followed by SWIPHA EXPORTS PRIVATE LIMITED at 19.3%. This supplier concentration could impact the company's ability to adapt to market changes or disruptions. The limited diversification in formulations, with 81 unique products, further underscores the need for strategic planning to mitigate potential supply chain vulnerabilities.

3Strategic Implications

Importing Pharmaceuticals into Myanmar — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Myanmar

1Regulatory Authority & Framework

In Myanmar, the Food and Drug Administration (FDA Myanmar), under the Ministry of Health, is the primary regulatory authority overseeing pharmaceutical imports. The National Drug Law, enacted in 1992, governs the registration, licensing, and quality assurance of pharmaceutical products. This legislation mandates that all pharmaceutical products intended for import, manufacture, or sale in Myanmar must be registered with FDA Myanmar to ensure safety, efficacy, and quality. (wipo.int)

2Import Licensing & GMP

Import licensing requirements in Myanmar stipulate that pharmaceutical products must be registered with FDA Myanmar before importation. The registration process involves submitting a dossier in the ASEAN Common Technical Dossier (ACTD) format, covering administrative, quality, non-clinical, and clinical data. Additionally, a Good Manufacturing Practice (GMP) certificate from the manufacturing facility is mandatory to demonstrate compliance with international quality standards.

3Quality & Labeling

YAR PYE Company Limited — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

YAR PYE Company Limited's focus on importing Ketoconazole, Cefixime, and Metoclopramide aligns with the therapeutic needs of the Myanmar market. These products address prevalent health concerns, including fungal infections, bacterial infections, and gastrointestinal disorders. The company's strategic emphasis on these categories suggests a targeted approach to meet the most pressing healthcare demands in the region.

2Sourcing Profile

The company's sourcing strategy is centered on high-quality generic drugs from India, particularly in the antifungal, advanced antibiotics, and gastrointestinal therapeutic areas. This focus indicates a preference for cost-effective solutions that do not compromise on quality, catering to the needs of the Myanmar market while maintaining competitive pricing.

3Market Positioning

Based on its product mix, YAR PYE Company Limited serves a broad segment of the Myanmar pharmaceutical market, including retail pharmacies, hospitals, and government tenders. The company's diverse product portfolio enables it to address various healthcare needs, positioning it as a comprehensive supplier in the pharmaceutical distribution network.

Seller's Guide — How to Become a Supplier to YAR PYE Company Limited

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to collaborate with YAR PYE Company Limited, particularly in the identified therapeutic categories. The company's concentrated sourcing pattern suggests potential gaps in its current portfolio, which new suppliers can fill by offering high-quality products that meet regulatory standards. However, establishing such partnerships would require navigating Myanmar's regulatory landscape and aligning with the company's quality and compliance requirements.

2Requirements & Qualifications

Indian exporters aiming to supply YAR PYE Company Limited must ensure that their products are registered with FDA Myanmar and possess a valid GMP certificate. Additionally, compliance with Myanmar's labeling requirements, including English language specifications, is essential. Understanding and adhering to the National Drug Law and related regulations will facilitate smoother market entry and partnership development.

3How to Approach

Frequently Asked Questions — YAR PYE Company Limited

What products does YAR PYE Company Limited import from India?

YAR PYE Company Limited imports 3 pharmaceutical products across 3 categories. Top imports: Ketoconazole ($350.0K), Cefixime ($300.0K), Metoclopramide ($200.0K).

Who supplies pharmaceuticals to YAR PYE Company Limited from India?

YAR PYE Company Limited sources from 4 verified Indian suppliers. The primary supplier is Maan Pharmaceuticals Limited (77.2% of imports, $1.2M).

What is YAR PYE Company Limited's total pharmaceutical import value?

YAR PYE Company Limited's total pharmaceutical import value from India is $850.0K, based on 17 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does YAR PYE Company Limited focus on?

YAR PYE Company Limited imports across 3 categories. The largest: Antifungals (41.2%), Advanced Antibiotics (35.3%), Gastrointestinal (23.5%).

Get Full YAR PYE Company Limited Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.